One of the most important indications for us to use CytoSorb® in is cardiac surgery, as it has also been cited in many guidelines.
It seems that applying the CytoSorb in combination with CRRT in ICU septic patients with AKI is correlated with a significant decrease in mortality.
Catecholamines decreased within 24 h after initiation of CytoSorb Therapy; in-hospital mortality was significantly lower in the CytoSorb group (35.7% vs 61.9%).
